medigraphic.com
ISSN 0016-3813 (Print)

2003, Number 2

<< Back Next >>

Gac Med Mex 2003; 139 (2)

Bone Marrow Failure Syndromes

Introduction.
Bone Marrow Failure Syndromes in Children.
Gene Therapy in Fanconi Anemia.
Therapeutic Options in Bone Marrow Aplasia.
Transient Bone Marrow Failure in Pediatric Acute Lymphoblastic Leukemia

Benítez-Aranda H, del Campo-Martínez MA, Frias S, Gómez-Almaguer D, Correa-González LC

Language: Spanish
References: 34
Page: 12-19
PDF size: 69.72 Kb.


Text Extraction

No abstract


REFERENCES

  1. Benítez-Aranda H. Síndromes de falla medular. I. Introducción. Gac Med Mex 2002; 138 (Supl 1): S-19.

  2. D’Andrea AD. Molecular pathogenesis of Fanconi Anemia: Implications for diagnosis and treatment. En: Broudy VC, Abkowitz JL, Vose JM, eds. Hematology 2002. Seattle: American Society of Hematology; 2002. p. 58-61.

  3. Dahl N. Molecular basis of Diamond-Blackfan anemia. En: Broudy VC, Abkowitz JL, Vose JN, eds. Hematology 2002. Seattle: American Society of Hematology; 2002. p. 61-3.

  4. Young NS, Alter BP. Aplastic anemia acquired and inherited. Philadelphia: WB Saunders; 1994. p. 46.

  5. Homans AC, Cohen JL, Barker BE. Aplastic presentation of acute lymphoblastic leukemia: Evidence for cellular inhibition of normal hematopoietic progenitors. Am J Pediatr Hematol Oncol 1989; 11: 456-62.

  6. Lanzkowsky P. Bone marrow failure. In: Manual of pediatric hematology and oncology. 3th edition. Academic press: 2000, p. 93-135.

  7. Alter BP, Young NS. The bone marrow failure syndromes. In: Nathan DG, Orkin SH, editors. Hematology of infancy and childhood, 5th edition. Philadelphia: WB Saunders, 1998, p. 237-335.

  8. Congenital bone marrow failure syndromes associated with protean developmental defects and leukemia. Clinics in Perinatology. 2002 Sep; 27 (3): 543-558.

  9. Molecular medicine and bone marrow failure syndromes. J Pediatr. 2000 Mar; 136 (3): 275–6.

  10. Bone marrow failure syndromes in children. Pediatric Clin North Am. 2002 Oct; 49 (5): 973-88. Review.

  11. Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anemia. Nat Rev Genet 2:446-457,2001.

  12. Esmer MC, Sanchez S, Ramos S, Molina B, Frias S, Carnevale A. DEB test for Fanconi Anemia detection in patients with atypical phenotype. Am J Med Genet. In press, 2003.

  13. D’Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 3:23-34, 2003.

  14. Liu JM, Kim S, Read EJ, Futaki M, Dokal I, Carter CS, Leitman SF, Pensiero M, Young NS, Walsh CE. Engraftment of Hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC). Hum Gene Therapy 10:2337-2346, 1999.

  15. Galimi F, Noll M, Kanazawa Y, Lax T, Chen C, Grompe M, Verma IM. Gene therapy of Fanconi anemia : Preclinical efficacy using lentiviral vectors. Blood, Prepublished on line.

  16. Young NS. Acquired aplastic anemia. Ann Intern Med. 2002;136:534-546.

  17. Ruiz-Argüelles GL, Díaz-Jouanen E. (Editorial) ¿ Existen formas autoinmunes de aplasia medular? Rev. Invest Clin Méx 1979; 32:195-196.

  18. Gómez-Almaguer D, Marfil-Rivera J, Kudish-Wersh A. Acyclovir in the treatment of aplastic anemia. Am J Hematol 1988; 45: 776-780

  19. Doeg HJ, Leisenring W, Storb R, et al. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood. 1998;91:3637-3645.

  20. Herrera-Garza JL, Jaime-Pérez JC, Montemayor JL, Ibarra-Peart RE, Gómez-Almaguer D. High dose peripheral blood stem cell transplant for multitransfused severe aplastic anemia patients without antithymocyte globulin in the conditioning regimen. Bone Marrow Transplant. 1999; 24:845-848.

  21. Hsu HC, Tsai WH, Lin JS, et al. Primary transplantation of allogeneic peripheral blood stem cell for severe aplastic anemia. Ann Hematol 1997; 74:191-192.

  22. Gómez-Almaguer D, Ruiz-Argüelles GJ, Tarín-Arzaga LC, et al. Non-myeloablative stem cell transplantation in children and adolescents: The mexican experience. Biol Blood Marrow Transpl 2003 in press.

  23. Camitta B, O’Reilly RJ, Sensenbrenner L, et al. Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia. Blood 1983;62:883-888.

  24. Frickhofen N, Heimpel H, Kaltwasser JP, et al. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of randomized trial comparing treatments of aplastic anemia. Blood 2003; 101:1236-1242.

  25. Jaime-Pérez-JC, González-Llano O, Gómez-Almaguer D. High dose cyclophosphamide in the treatment of severe aplastic anemia in children. Am J Hematol 2002; 66:71

  26. Morales-Polanco MR, Sánchez-Valle E, Guerrero-Rivera S, et al. Treatment results of 23 cases of severe aplastic anemia with lymphocytopheresis. Arch Med Res 1997; 28:85-90.

  27. Reid MM, Summerfield GP. Distinction between aleukaemic prodrome of childhood acute lymphoblastic leukaemia and aplastic anaemia. J Clin Pathol 1992, 45: 697-700.

  28. Breatnach F, Chessells JM, Greaves MF. The aplastic presentation of childhood leukaemia: a feature of Common-ALL. Br J Haematol 1981, 49: 387-393.

  29. Matloub YH, Brunning RD, Arthur D. Severe Aplastic Anemia Preceding Acute Lymphoblastic Leukemia. Cancer 1993, 71: 264-268.

  30. Melhorn DK, Gross S. Acute Childhood leukemia presenting as aplastic anemia. The response to corticosteroids. J Pediatr 1970, 77: 647-652.

  31. Sills RH, Stockman JA. Preleukemic States in Children with Acute Lymphoblastic Leukemia. Cancer 1981, 48: 110-112.

  32. Liang R, Cheng G, Wat MS. Childhood acute lymphoblastic leukaemia presenting with relapsing hypoplastic anaemia: progression of the same abnormal clone. Br J Haematol 1993, 83: 340-342.

  33. Homans AC, Cohen JL, Barker BE. Aplastic presentation of Acute Lymphoblastic Leukemia: Evidence for Cellular Inhibition of Normal Hematopoietic Progenitors. Am J Pediatr Hematol Oncol 1989, 11: 456-462.

  34. Saarinen UM, Wegelius R. Preleukemic syndrome in children. Report of four cases and review of literature. Am J Pediatr Hematol Oncol 1984, 6: 137-145.




2020     |     www.medigraphic.com